Search Legislation

The Misuse of Drugs Act 1971 (Modification) Order 1996

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As made)
 Help about opening options

Opening Options

More Resources

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

2.—(1) Schedule 2 to the Misuse of Drugs Act 1971(1) (which specifies the drugs which are subject to control under that Act) shall be amended as follows.

(2) In paragraph 1 of Part III of that Schedule

(a)the list of substances and products beginning with“Alprazolam”and ending with “Triazolam”shall be designated sub-paragraph (a), and accordingly “(a)”shall be inserted before “Alprazolam”; and

(b)there shall be added at the end the following sub-paragraphs —

(b)Atamestane.

  • Bolandiol.

  • Bolasterone.

  • Bolazine.

  • Boldenone.

  • Bolenol.

  • Bolmantalate.

  • Calusterone.

  • 4-Chloromethandienone.

  • Clostebol.

  • Drostanolone.

  • Enestebol.

  • Epitiostanol.

  • Ethyloestrenol.

  • Fluoxymesterone.

  • Formebolone.

  • Furazabol.

  • Mebolazine.

  • Mepitiostane.

  • Mesabolone.

  • Mestanolone.

  • Mesterolone.

  • Methandienone.

  • Methandriol.

  • Methenolone.

  • Methyltestosterone.

  • Metribolone.

  • Mibolerone.

  • Nandrolone.

  • Norboletone.

  • Norclostebol.

  • Norethandrolone.

  • Ovandrotone.

  • Oxabolone.

  • Oxandrolone.

  • Oxymesterone.

  • Oxymetholone.

  • Prasterone.

  • Propetandrol.

  • Quinbolone.

  • Roxibolone.

  • Silandrone.

  • Stanolone.

  • Stanozolol.

  • Stenbolone.

  • Testosterone.

  • Thiomesterone.

  • Trenbolone.

(c)any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,

(i)by further substitution at position 17 by a methyl or ethyl group;

(ii)by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

(iii)by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(iv)by fusion of ring A with a heterocyclic system;

(d)any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above;

(e)Chorionic Gonadotrophin (HCG).

  • Clenbuterol.

  • Non-human chorionic gonadotrophin.

  • Somatotropin.

  • Somatrem.

  • Somatropin..

(1)

Schedule 2 has been amended by S.I. 1973/771, 1975/421, 1977/1243, 1979/299, 1983/765, 1984/859, 1985/1995, 1986/2230, 1989/1340, 1990/2589 and 1995/1966.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources